您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Adenosine Dialdehyde(ADOX)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Adenosine Dialdehyde(ADOX)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Adenosine Dialdehyde(ADOX)图片
CAS NO:34240-05-6
规格:≥98%
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
250mg电议
500mg电议

产品介绍
理化性质和储存条件
Molecular Weight (MW) 265.23
Formula C10H11N5O4
CAS No. 34240-05-6
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 19 mg/mL (71.6 mM)
Water: 3 mg/mL (11.3 mM)
Ethanol: < 1 mg/mL
Solubility (In vivo)
Synonyms ADOX
SMILES Code
实验参考方法
In Vitro

In vitro activity: Adenosine dialdehyde acts as an indirect inhibitor that can be incorporated by cells. The inhibition of S-adenosyl-L-homocystein hydrolase by ADOX can lead to the accumulation of S-adenosyl-L-homo cystein (Adoicy), a product inhibitor of methyltransferases that utilize S-adenosyl-L-methionine (AdoMet) as the methyl group donor. ADOX inhibited the Tax-activated NF-κB pathway, resulting in reactivation of p53 and induction of p53 target genes.


Kinase Assay:


Cell Assay: Hela cells are grown in MEM medium supplemented with 10% fetal bovine serum at 37 ℃ in a 5% CO2 incubator. Treatment of cells with ADOX for various time periods was performed. The cells are harvested and washed with phosphate-buffered saline, resuspended in buffer A (phosphate-buffered saline with 5% glycerol, 1 mM sodium EGTA, 1 mM dithiothreitol, 0.5% Triton X-100 and Complete protease inhibitor cocktail).

In VivoADOX exerts a potent inhibitory effect on the in situ growth of established murine neuroblastoma (MNB) tumors, prolongs the life span of tumor bearing mice, and does not suppress hematopoiesis when administered by steady state infusion. ADOX inhibits the replication of L1210 leukemia cells and increased life span approximately 40% when administered i.p. at a dose of 20 mg/kg/day until death.
Animal model Murine Neuroblastoma Tumor Model
Formulation & Dosage Formulated in DMSO (3.3%, v/v), ethanol (50%, v/v) and saline (46.7%, v/v); 1.5 to 2.5 mg/kg/day; s.c.
References Cancer Res. 1987 Jul 15;47(14):3656-61; J Med Chem. 1988 Sep;31(9):1798-804.